The final, formatted version of the article will be published soon. Background: The objective of this study was to conduct a systematic review and network meta-analysis (NMA) to compare the efficacy ...
In postmenopausal women with osteoporosis, prior fracture, and type 2 diabetes, 12 months of romosozumab significantly improved bone strength when combined with alendronate, compared with alendronate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback